Author

Miranda A. Robert

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Kailan Sierra-DavidsoniD· 1 shared Lance L. MunniD· 1 shared Lingshan LiuiD· 1 shared Lutz MenzeliD· 1 shared Meghan J. O’MeliaiD· 1 shared Pin‐Ji LeiiD· 1 shared Sonia CoheniD· 1 shared Timothy P. PaderaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Kailan Sierra-DavidsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The anti-virus T cell response dominates the anti-cancer response in oncolytic virus therapy

Meghan J. O’Melia, Kailan Sierra-Davidson, Miranda A. Robert, Lutz Menzel, Lingshan Liu, Pin‐Ji Lei, Lance L. Munn, Timothy P. Padera, Sonia Cohen

This study shows oncolytic virus therapy primarily elicits anti-virus T cell responses rather than anti-cancer responses, explaining limited clinical efficacy in metastatic disease.

bioRxiv · Sep 22, 2025 · PreprintImmunology